Kenvue Inc (KVUE) Stock Analysis
Verdict: HOLD
Stabilizing fundamentals and a 4.4% yield provide a defensive floor, while M&A chatter with Kimberly-Clark serves as a volatile upside cap.
Investment score: 64/100
Analysis as of
Is Kenvue Inc stock worth reviewing? The TradeMates thesis
Kenvue is an income play with a pending M&A catalyst. While margins are elite (58%+), the market has largely priced in the stability.
7-factor investment score
- Valuation: 55/100 (weight 20%)
- Financial Health: 65/100 (weight 15%)
- Technical Momentum: 60/100 (weight 15%)
- Earnings Quality: 85/100 (weight 15%)
- Insider Sentiment: 40/100 (weight 10%)
- Analyst Consensus: 50/100 (weight 10%)
- Risk-Adjusted Return: 75/100 (weight 15%)
Kenvue Inc opportunities and risks
What speaks for KVUE
- FDA Approval of Tylenol/Naproxen Combo
What speaks against KVUE
- Unsustainable Payout Ratio
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| KVUE | 22.7x | 2.4x | 14.1x | 58.4% | 10.6% | 4.9% |
| EL | n/a | 2.0x | 26.2x | 73.4% | -1.7% | 4.4% |
| ELF | 167.7x | 2.8x | 32.3x | 70.7% | 1.6% | 4.2% |
| IPAR | 23.2x | 2.6x | 13.2x | 64.0% | 11.3% | 5.1% |
| BRBR | 9.9x | 0.6x | 8.6x | 28.9% | 6.8% | 12.4% |
| COTY | n/a | 0.4x | 55.9x | 60.7% | -9.2% | 13.3% |
| Peer median | 9.9x | 2.0x | 26.2x | 64.0% | 1.6% | 5.1% |
Frequently asked questions about Kenvue Inc (KVUE)
Is KVUE stock a good investment?
The TradeMates model rates Kenvue Inc as HOLD with an investment score of 64/100. Kenvue is an income play with a pending M&A catalyst. While margins are elite (58%+), the market has largely priced in the stability. This is algorithmic model output, not personal investment advice.
Is KVUE stock a buy?
The TradeMates model verdict for KVUE is HOLD with an investment score of 64/100. Treat this as a model signal to review, not a personal buy recommendation.